VC in China

Last registered on June 23, 2020
View Trial History

Pre-Trial

Trial Information

General Information

Title
VC in China
RCT ID
AEARCTR-0006039
Initial registration date
June 22, 2020

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
June 23, 2020, 11:10 AM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Locations

Country
China
Region

Primary Investigator

Name
Emanuele Colonnelli
Affiliation
Contact Primary Investigator

Other Primary Investigator(s)

Additional Trial Information

Status
On going
Start date
2019-04-01
End date
2021-04-01
Keywords
Finance & Microfinance, Firms & Productivity, Governance
Additional Keywords
JEL code(s)
Secondary IDs
Abstract
This study aims to estimate the preferences of venture capital investors in China.
External Link(s)

Registration Citation

Citation
Colonnelli, Emanuele. 2020. "VC in China." AEA RCT Registry. June 23. https://doi.org/10.1257/rct.6039-1.0
Sponsors & Partners
Experimental Details

Interventions

Intervention(s)
This study aims to estimate the preferences of venture capital investors in China using an incentivized choice experiment with real stakes.
Intervention Start Date
2019-04-01
Intervention End Date
2020-06-30

Primary Outcomes

Primary Outcomes (end points)
Choice of an investment partner with specific characteristics.
Primary Outcomes (explanation)
See pdf attachment for additional details.

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
This study aims to estimate the preferences of venture capital investors in China using an incentivized choice experiment with real stakes.
Experimental Design Details
See pdf attachment for additional details.
Randomization Method
Randomization done in office by a computer.
Randomization Unit
Randomization is done to ensure that profiles are randomly created. See pdf attachment for additional details.
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
Approximately 800 fund managers and 300 investors.
Sample size: planned number of observations
Approximately 22,000 (800*20+300*20)
Sample size (or number of clusters) by treatment arms
See pdf attachment for additional details.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials
IRB

Institutional Review Boards (IRBs)

IRB Name
IRB Approval Date
IRB Approval Number
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Post-Trial

Post Trial Information

Study Withdrawal

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Intervention

Is the intervention completed?
No
Data Collection Complete
Data Publication

Data Publication

Is public data available?
No

Program Files

Program Files
Reports, Papers & Other Materials

Relevant Paper(s)

Reports & Other Materials